Status:
COMPLETED
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
Lead Sponsor:
Practitioners Alliance Network
Conditions:
Alzheimer's Disease
Dementia
Eligibility:
All Genders
Phase:
NA
Brief Summary
Treating with measures that may improve metabolic functioning of neurons in an integrated protocol
Detailed Description
Most organ failure results in modest drops in function until over 50% of function is lost. At a certain point, even modest drops in physiologic activity result in dramatic drops in clinical function. ...
Eligibility Criteria
Inclusion
- A diagnosis of Alzheimer's and/or dementia with an MMSE score over 12 or being ambulatory and able to travel outside the home with assistance.
- Must have a caregiver living with them.
Exclusion
- Overt progressive and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
- Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2017
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT02260167
Start Date
September 1 2014
End Date
December 1 2017
Last Update
May 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PAN
Kailua, Hawaii, United States, 96740